Literature DB >> 7538646

Calbindin D28k-containing neurons are restricted to the medial substantia nigra in humans.

D A McRitchie1, G M Halliday.   

Abstract

A controversy exists in the literature as to whether neurons containing the calcium binding protein calbindin-D28k are located within the human substantia nigra. The point of variance between reports, however, is not the anatomical distribution of these neurons, but rather the delineation of the dorsal border of the substantia nigra. It has been suggested that the dense substance P striatonigral innervation delimits the substantia nigra in the human. The aim of the present study is to re-examine the distribution of calbindin-D28k-positive neurons throughout the substantia nigra using substance P to delimit its borders. Although a few calbindin-D28k-positive neurons were found in the medial cell group of the substantia nigra, the vast majority of positive neurons were located in the adjacent A8 and A10 dopaminergic cell groups. This anatomical location of calbindin-D28k-positive neurons is consistent with previous reports, though our results indicate that when the striatonigral projection is used to define the substantia nigra, calbindin-D28k is not a notable feature of these neurons. This questions the neuroprotective role of this protein in Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7538646     DOI: 10.1016/0306-4522(94)00483-l

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  12 in total

Review 1.  The neuroanatomic complexity of the CRF and DA systems and their interface: What we still don't know.

Authors:  E A Kelly; J L Fudge
Journal:  Neurosci Biobehav Rev       Date:  2018-04-25       Impact factor: 8.989

Review 2.  The reward circuit: linking primate anatomy and human imaging.

Authors:  Suzanne N Haber; Brian Knutson
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

Review 3.  The place of dopamine in the cortico-basal ganglia circuit.

Authors:  S N Haber
Journal:  Neuroscience       Date:  2014-10-19       Impact factor: 3.590

4.  Regional dopamine transporter gene expression in the substantia nigra from control and Parkinson's disease brains.

Authors:  T J Counihan; J B Penney
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

5.  Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease.

Authors:  Tomás González-Hernández; Ignacio Cruz-Muros; Domingo Afonso-Oramas; Josmar Salas-Hernandez; Javier Castro-Hernandez
Journal:  Front Neuroanat       Date:  2010-10-20       Impact factor: 3.856

Review 6.  The extended amygdala and the dopamine system: another piece of the dopamine puzzle.

Authors:  Julie L Fudge; Ana B Emiliano
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2003       Impact factor: 2.198

7.  Differential actions of AMP kinase on ATP-sensitive K+ currents in ventral tegmental area and substantia nigra zona compacta neurons.

Authors:  Yan-Na Wu; Ke-Zhong Shen; Steven W Johnson
Journal:  Eur J Neurosci       Date:  2017-11-06       Impact factor: 3.386

8.  Catechol-O-methyltransferase genotype and dopamine regulation in the human brain.

Authors:  Mayada Akil; Bhaskar S Kolachana; Debora A Rothmond; Thomas M Hyde; Daniel R Weinberger; Joel E Kleinman
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

9.  Loss of DARPP-32 and calbindin in multiple system atrophy.

Authors:  Hideki Hayakawa; Makiko Nagai; Aya Kawanami; Yasuto Nakata; Tomoko Nihira; Mieko Ogino; Masahiko Takada; Takaomi Saido; Jiro Takano; Makoto Saegusa; Tetsuo Mikami; Junichi Hamada; Kazutoshi Nishiyama; Hideki Mochizuki; Yoshikuni Mizuno
Journal:  J Neural Transm (Vienna)       Date:  2013-05-29       Impact factor: 3.575

Review 10.  Corticostriatal circuitry.

Authors:  Suzanne N Haber
Journal:  Dialogues Clin Neurosci       Date:  2016-03       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.